Word

BELLA LOVES ME

Status

Dead

Status Code

606

Status Date

Monday, February 13, 2023

Serial Number

90455609

Mark Type

4000

Filing Date

Friday, January 8, 2021

Published for Opposition

Tuesday, May 17, 2022

Abandoned Date

Monday, February 13, 2023

Trademark Owner History

LivePerson, Inc. - Owner At Publication

Classifications

9 Downloadable computer application software for mobile phones, namely, software for covid-19 and other infectious disease identification; Downloadable computer application software for computers, namely, software for covid-19 and other infectious disease identification; Downloadable mobile applications for health screenings relating to COVID-19 and other infectious disease; Downloadable mobile applications for tracking and reporting health conditions and symptoms; Medical, clinical, and scientific laboratory research instruments for identifying and testing pathogens and biomarkers in respiratory droplets related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical and medical laboratory research, and scientific purposes, namely, for COVID-19 and other infectious diseases

5 Diagnostic kits comprised of medical diagnostic assays for use in disease detection, screening, treating and monitoring, namely, monitoring COVID-19 and other infectious diseases; Respiratory rapid tests, namely, medical diagnostic assays for use in performing respiratory rapid tests related to COVID-19 and other infectious diseases; Medical diagnostic kits comprised of reagents and assays for use in disease detection, screening, treating and monitoring, including, monitoring COVID-19 and other infectious diseases and also including swabs, including nasal and throat swabs, and medical sample tubes; COVID-19 rapid tests comprising medical diagnostic reagents and assays for withdrawing and testing respiratory droplets and also including parts and fittings thereof

35 Appointment scheduling services for mobile healthcare patients in the field of Covid-19 and other infectious diseases

1 COVID-19 rapid tests comprising reagents and assays for withdrawing and testing respiratory droplets for clinical, medical laboratory, research, and scientific purposes and also including parts and fittings thereof

45 Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying physical sites visited by persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments; Information collection and management services in the field of public health, namely, collecting, verifying, tracing, tracking, storing, monitoring, and notifying contacts of persons infected with contagious disease for the purpose of slowing or stopping the spread of the disease under the guidance of state and local public health departments

44 Healthcare services, namely, treatment of patients for infectious diseases or medical disorders; Medical and healthcare information, consultancy and advisory services relating to infections, viruses, SARS-CoV-2, COVID-19, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Providing a web site featuring medical information; Health care services, namely, disease management programs; Telehealth services, namely, providing telemedicine and services in conjunction with providing medical and healthcare services; Mobile healthcare services in the field of Covid-19 and other infectious disease testing, health assessments, and intravenous infusion therapy, facilitating; Medical screening services in the field of Covid-19 and other infectious diseases in a patient; Polymerase chain reaction (PCR) testing, rapid body antigen testing, and nucleic acid amplification testing for identifying and testing pathogens and biomarkers in respiratory droplets for medical diagnostic purposes related to COVID-19 and other infectious diseases

10 Medical instruments, namely, biosensors for detecting Covid-19 and other infectious diseases in a patient; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for medical diagnostic purposes, namely, for COVID-19 and other infectious diseases

42 Providing temporary use of online non-downloadable software for use in the testing and diagnosis of COVID-19, coronavirus, and other diseases; Scientific apparatus and instruments, namely, COVID-19 rapid tests for withdrawing and testing respiratory droplets for clinical, medical, research, and scientific purposes and parts and fittings thereof; Material testing apparatus and instruments, for identifying and testing pathogens and biomarkers in respiratory droplets for clinical, medical, research, and scientific purposes related to COVID-19 and other infectious diseases; Apparatus for transmission of communication; Monitoring, measuring, signaling and control apparatus and instruments for testing respiratory droplets against a panel of biomarkers for clinical, medical, research, and scientific purposes, namely, for COVID-19 and other infectious diseases; Providing temporary use of online non-downloadable software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Providing temporary use of web-based software applications for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Software as a service (SAAS) services featuring software for health screenings relating to COVID-19 and other infectious diseases and for tracking and reporting health conditions and symptoms; Electronic storage of information concerning persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments, and information concerning physical sites visited by persons infected with contagious disease for the purpose slowing or stopping the spread of the disease under the guidance of state and local public health departments

Trademark Events

Feb 13, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Feb 13, 2023

Abandonment - No Use Statement Filed

Nov 16, 2022

Assigned To Examiner

Jul 12, 2022

Noa E-Mailed - Sou Required From Applicant

May 17, 2022

Official Gazette Publication Confirmation E-Mailed

May 17, 2022

Published For Opposition

Apr 27, 2022

Notification Of Notice Of Publication E-Mailed

Apr 13, 2022

Approved For Pub - Principal Register

Apr 12, 2022

Teas/Email Correspondence Entered

Apr 12, 2022

Correspondence Received In Law Office

Apr 12, 2022

Teas Request For Reconsideration Received

Apr 8, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Apr 8, 2022

Teas Change Of Correspondence Received

Apr 8, 2022

Teas Change Of Owner Address Received

Oct 13, 2021

Notification Of Final Refusal Emailed

Oct 13, 2021

Final Refusal E-Mailed

Oct 13, 2021

Final Refusal Written

Oct 5, 2021

Teas/Email Correspondence Entered

Oct 5, 2021

Correspondence Received In Law Office

Oct 5, 2021

Teas Response To Office Action Received

Jul 14, 2021

Notification Of Non-Final Action E-Mailed

Jul 14, 2021

Non-Final Action E-Mailed

Jul 14, 2021

Non-Final Action Written

Jul 7, 2021

Assigned To Examiner

Apr 8, 2021

New Application Office Supplied Data Entered

Jan 12, 2021

New Application Entered